IPP Bureau
Glenmark Pharmaceuticals to address USFDA’s observation
By IPP Bureau - June 23, 2022
U.S. FDA has issued Form 483 with six observations after an inspection of the company’s formulation manufacturing facility based out of Baddi
Alembic Pharmaceuticals shows growth in May 2022
By IPP Bureau - June 23, 2022
Ex-Azithromycin has shown a growth of 8% and 14% in April 2022 and May 2022 respectively
Avni announces subscription model menstrual hygiene products
By IPP Bureau - June 23, 2022
The array available for a subscription includes popular products to make menstrual hygiene a regular practice and extend further affordability to its users
Piramal Pharma Solutions appoints Herve Berdou as COO
By IPP Bureau - June 23, 2022
Brings 25 years of global operations and supply chain experience to Piramal
Nippon Express launches new transport service using environmental-friendly isothermal packaging
By IPP Bureau - June 23, 2022
Becomes first Japanese logistics company to collaborate with EMBALL’ISO, which has a proven track record in vaccine transport
Indian Pharma Post organizes e-Conference on ‘Role of Digitalization in Pharma Sector’ June 24
By IPP Bureau - June 23, 2022
Sanjay Verma of Akums Drugs & Pharmaceuticals, Manu Gupta of Cadila Pharmaceuticals, Rahul Borse of RPG Life Sciences, Krishna Sai T of Biocon and Amit Saluja of NASSCOM are speakers
IOL Life Sciences incorporated as a subsidiary of IOL Chemicals and Pharmaceuticals
By IPP Bureau - June 22, 2022
The company is strategically expanding its product portfolio with a pipeline of new products that will form a strong foundation for future growth.
Merck presents positive results from phase 1/2 study evaluating V116
By IPP Bureau - June 22, 2022
V116 designed to target serotypes that account for 85% of all invasive pneumococcal disease in individuals aged 65 and over in the United States as of 2019
Merck appoints Chirfi Guindo as CMO for Merck Human Health
By IPP Bureau - June 22, 2022
Guindo will be responsible for leading the development and implementation of the company’s long-term strategy for the Human Health portfolio.
Briefs: Marksans Pharma and Alkem
By IPP Bureau - June 22, 2022
The US FDA had conducted an inspection of Alkem Laboratories Limited's manufacturing facility located at St. Louis, USA.
Agilent Laboratory achieves Green Lab certification
By IPP Bureau - June 22, 2022
This is the first Agilent lab to receive the My Green Lab Certification and plans are under way to certify additional labs.
AstraZeneca and Merck announces results from phase 3 PROpel trial of Lynparza
By IPP Bureau - June 22, 2022
LYNPARZA is approved in the U.S. for patients with HRR gene-mutated mCRPC (BRCA-mutated and other HRR gene mutations)
MedC Biopharma partners with A2W Pharma to develop cannabinoid therapeutics
By IPP Bureau - June 22, 2022
Bringing next-gen cannabinoid therapeutics to cancer patients
Atik Cameras launches ChemiMOS for long exposure imaging
By IPP Bureau - June 22, 2022
Atik Cameras launches ChemiMOS; A 9MP CMOS camera for scientific applications
Sadhana Nitro Chem commences production of its 1st para aminophenol plant
By IPP Bureau - June 22, 2022
The company is now introducing the product into the India pharmaceutical market.
